Effect of Propofol on Postoperative Nausea and Vomiting in Patients Undergoing Elective Cesarean Section under Spinal Anesthesia: A Randomized Clinical Trial
DOI:
https://doi.org/10.51985/JBUMDC2024488Keywords:
Elective cesarean, Postoperative nausea and vomiting, Propofol, Spinal anesthesiaAbstract
Objective: To analyze anti-emetic effect of sub-hypnotic dose of Propofol in patients undergoing cesarean section. Study Design and Setting: Prospective, Interventional Randomized Clinical trial done at PAF Hospital Islamabad, from 1stAugust 2021 to 31stJanuary 2022.
Methodology: A total of 60 patients undergoing elective cesarean under spinal anesthesia were selected for the study. Selected patients were randomly allocated either of the two groups. Patients included in the Group A received sub hypnotic intravenous dose of Propofol as per their body weight, whereas the Group B patients received intravenous saline (0.9%). Postoperative nausea and vomiting was assessed during patients’ PACU stay of 1 hour using the subjective feelings of the patients. If the patient complains of vomiting in PACU, an intravenous dose of 10mg Metoclopramide was given as rescue antiemetic.
Results: Mean age of patients was 30.73±4.51 years. APFEL score 3 was observed in 15 (50.0%) in group A and 15 (50.0%) in group B. Score 4 was observed in 4 (13.3%) in group A and 08 (26.7%) in group B( p-value 0.33).Vomiting was observed in 06 (20.0%) in group A and 24 (80.0%) in group B respectively( p-value of <0.01).Nausea was found in 08 (26.7%) in group A and 25 (83.3%) in group B (p-value <0.01).
Conclusion: Propofol in sub-hypnotic dose is effective in the prevention of postoperative nausea and vomiting in patients undergoing cesarean section under spinal anesthesia
Downloads
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Bahria University Medical & Dental College is an open access journal and is licensed under CC BY-NC 4.0. which permits unrestricted non commercial use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0